chr10-45826112-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001276343.3(AGAP4):c.1864G>A(p.Gly622Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001276343.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGAP4 | NM_001276343.3 | c.1864G>A | p.Gly622Arg | missense_variant | Exon 8 of 8 | ENST00000616763.6 | NP_001263272.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGAP4 | ENST00000616763.6 | c.1864G>A | p.Gly622Arg | missense_variant | Exon 8 of 8 | 1 | NM_001276343.3 | ENSP00000483751.2 | ||
AGAP4 | ENST00000448048.7 | c.1795G>A | p.Gly599Arg | missense_variant | Exon 7 of 7 | 1 | ENSP00000392513.2 |
Frequencies
GnomAD3 genomes Cov.: 19
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000734 AC: 10AN: 1362632Hom.: 0 Cov.: 28 AF XY: 0.0000103 AC XY: 7AN XY: 678530
GnomAD4 genome Cov.: 19
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1795G>A (p.G599R) alteration is located in exon 7 (coding exon 7) of the AGAP4 gene. This alteration results from a G to A substitution at nucleotide position 1795, causing the glycine (G) at amino acid position 599 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at